The efficacy of Link N as a mediator of repair in a rabbit model of intervertebral disc degeneration

Arthritis Research and Therapy

Volumn 13, Issue 4, 2011, Pages

  Mwale, Fackson ^a,b   Masuda, Koichi ^c   Pichika, Rajeswari ^c   Epure, Laura M ^b   Yoshikawa, Tomoaki ^c   Hemmad, Aseem ^c   Roughley, Peter J ^d   Antoniou, John ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AGGRECANASE 1; AGGRECANASE 2; COLLAGEN TYPE 1; COLLAGEN TYPE 2; DNA; GLYCOSAMINOGLYCAN POLYSULFATE; METALLOPROTEINASE; PROTEIN LINK N; PROTEINASE K; PROTEOGLYCAN; RNA; SODIUM CHLORIDE; STROMELYSIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; LINK PROTEIN; PEPTIDE; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE BIOPSY; CHEMICAL ANALYSIS; CLINICAL EVALUATION; CONTROLLED STUDY; DNA CONTENT; GENE EXPRESSION; HISTOLOGY; IN VIVO STUDY; INTERVERTEBRAL DISK DEGENERATION; LUMBAR DISK; LUMBAR PUNCTURE; NONHUMAN; NUCLEUS PULPOSUS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD REGENERATION; SPINE RADIOGRAPHY; ANIMAL; DISEASE MODEL; DRUG EFFECT; EXTRACELLULAR MATRIX; INTRAARTICULAR DRUG ADMINISTRATION; PATHOLOGY; RABBIT;

ANIMALS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; INJECTIONS, INTRA-ARTICULAR; INTERVERTEBRAL DISC DEGENERATION; PEPTIDES; PROTEOGLYCANS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960579268     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3423     Document Type: Article

References (42)

1. Vanharanta H. The intervertebral disc: a biologically active tissue challenging therapy. Ann Med 1994, 26:395-399. 10.3109/07853899409148359, 7695863.
2. Luoma K, Riihimaki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A. Low back pain in relation to lumbar disc degeneration. Spine 2000, 25:487-492. 10.1097/00007632-200002150-00016, 10707396.
3. Abramovitz JN, Neff SR. Lumbar disc surgery: results of the prospective lumbar discectomy study of the joint section on disorders of the spine and peripheral nerves of the american association of neurological surgeons and the congress of neurological surgeons. Neurosurgery 1991, 29:301-307. 10.1227/00006123-199108000-00027, 1886676.
4. Roughley PJ. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine 2004, 29:2691-2699. 10.1097/01.brs.0000146101.53784.b1, 15564918.
5. Oegema TR. Biochemistry of the intervertebral disc. Clin Sports Med 1993, 12:419-439.
6. Watanabe H, Yamada Y, Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J Biochem (Tokyo) 1998, 124:687-693.
7. Handa T, Ishihara H, Ohshima H, Osada R, Tsuji H, Obata K. Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine 1997, 22:1085-1091. 10.1097/00007632-199705150-00006, 9160466.
8. Hutton WC, Elmer WA, Boden SD, Hyon S, Toribatake Y, Tomita K, Hair GA. The effect of hydrostatic pressure on intervertebral disc metabolism. Spine 1999, 24:1507-1515. 10.1097/00007632-199908010-00002, 10457568.
9. Hsieh AH, Lotz JC. Prolonged spinal loading induces matrix metalloproteinase-2 activation in intervertebral discs. Spine 2003, 28:1781-1788. 10.1097/01.BRS.0000083282.82244.F3, 12923463.
10. Kang JD, Stefanovic-Racic M, McIntyre LA, Georgescu HI, Evans CH. Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 1997, 22:1065-1073. 10.1097/00007632-199705150-00003, 9160463.
11. Goupille P, Jayson MI, Valat JP, Freemont AJ. Matrix metalloproteinases: the clue to intervertebral disc degeneration?. Spine 1998, 23:1612-1626. 10.1097/00007632-199807150-00021, 9682320.
12. Oegema TR, Johnson SL, Aguiar DJ, Ogilvie JW. Fibronectin and its fragments increase with degeneration in the human intervertebral disc. Spine 2000, 25:2742-2747. 10.1097/00007632-200011010-00005, 11064518.
13. Liu GZ, Ishihara H, Osada R, Kimura T, Tsuji H. Nitric oxide mediates the change of proteoglycan synthesis in the human lumbar intervertebral disc in response to hydrostatic pressure. Spine 2001, 26:134-141. 10.1097/00007632-200101150-00005, 11154531.
14. Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS. mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine 2002, 27:911-917. 10.1097/00007632-200205010-00005, 11979160.
15. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 2000, 25:3005-3013. 10.1097/00007632-200012010-00007, 11145811.
16. Annunen S, Paassilta P, Lohiniva J, Perala M, Pihlajamaa T, Karppinen J, Tervonen O, Kroger H, Lahde S, Vanharanta H, Ryhänen L, Göring HHH, Ott J, Prockop DJ, Ala-Kokko L. An allele of COL9A2 associated with intervertebral disc disease. Science 1999, 285:409-412. 10.1126/science.285.5426.409, 10411504.
17. Kawaguchi Y, Osada R, Kanamori M, Ishihara H, Ohmori K, Matsui H, Kimura T. Association between an aggrecan gene polymorphism and lumbar disc degeneration. Spine 1999, 24:2456-2460. 10.1097/00007632-199912010-00006, 10626307.
18. Smith L. Enzyme dissolution of the nucleus pulposus in humans. JAMA 1964, 187:137-140.
19. Krempen JF, Minnig DI, Smith BS. Experimental studies on the effect of chymopapain on nerve root compression caused by intervertebral disk material. Clin Orthop 1975, 106:336-349.
20. Masuda K, An HS. Growth factors and the intervertebral disc. Spine J 2004, 4:330S-340S. 10.1016/j.spinee.2004.07.028, 15541686.
21. An HS, Takegami K, Kamada H, Nguyen CM, Thonar EJ, Singh K, Andersson GB, Masuda K. Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine 2005, 30:25-31.
22. Masuda K, Imai Y, Okuma M, Muehleman C, Nakagawa K, Akeda K, Thonar E, Andersson G, An HS. Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine 2006, 31:742-754. 10.1097/01.brs.0000206358.66412.7b, 16582847.
23. Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, Hotta T. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine 2005, 30:2379-2387. 10.1097/01.brs.0000184365.28481.e3, 16261113.
24. Henriksson HB, Svanvik T, Jonsson M, Hagman M, Horn M, Lindahl A, Brisby H. Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine 2009, 34:141-148. 10.1097/BRS.0b013e31818f8c20, 19112334.
25. Wei A, Brisby H, Chung SA, Diwan AD. Bone morphogenetic protein-7 protects human intervertebral disc cells in vitro from apoptosis. Spine J 2008, 8:466-474. 10.1016/j.spinee.2007.04.021, 18082466.
26. Yoon ST, Park JS, Kim KS, Li J, Attallah-Wasif ES, Hutton WC, Boden SD. LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine 2004, 29:2603-2611. 10.1097/01.brs.0000146103.94600.85, 15564908.
27. Tolonen J, Gronblad M, Virri J, Seitsalo S, Rytomaa T, Karaharju E. Transforming growth factor beta receptor induction in herniated intervertebral disc tissue: an immunohistochemical study. Eur Spine J 2001, 10:172-176. 10.1007/s005860000213, 11345640.
28. Shen B, Wei A, Tao H, Diwan AD, Ma DD. BMP-2 enhances TGF-β3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A 2009, 15:1311-1320. 10.1089/ten.tea.2008.0132, 18950289.
29. McKenna LA, Liu H, Sansom PA, Dean MF. An N-terminal peptide from link protein stimulates proteoglycan biosynthesis in human articular cartilage in vitro. Arthritis Rheum 1998, 41:157-162. 10.1002/1529-0131(199801)41:1<157::AID-ART19>3.0.CO;2-J, 9433881.
30. Mwale F, Demers CN, Petit A, Roughley PJ, Poole AR, Steffen T, Aebi M, Antoniou J. A synthetic peptide of link protein stimulates the biosynthesis of collagens II, IX and proteoglycan by cells of the intervertebral disc. J Cell Biochem 2003, 88:1202-1213. 10.1002/jcb.10479, 12647302.
31. Petit A, Yao G, Rowas SA, Gawri R, Epure LM, Antoniou J, Mwale F. Effect of synthetic Link N peptide on the type I and type II collagens in human intervertebral discs cells. Tissue Eng Part A 2011, 17:899-904. 10.1089/ten.tea.2010.0494, 21067464.
32. Dean MF, Sansom P. Link peptide cartilage growth factor is degraded by membrane proteinases. Biochem J 2000, 349:473-479. 10.1042/0264-6021:3490473, 1221170, 10880346.
33. Liu H, McKenna LA, Dean M. An N-terminal peptide from link protein stimulates synthesis of cartilage proteoglycans. Biochem Soc Trans 1997, 25:427S.
34. Liu H, McKenna LA, Dean MF. The macromolecular characteristics of cartilage proteoglycans do not change when synthesis is up-regulated by link protein peptide. Biochim Biophys Acta 1999, 1428:191-200.
35. Masuda K, Aota Y, Muehleman C, Imai Y, Okuma M, Thonar EJ, Andersson GB, An HS. A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine 2005, 30:5-14.
36. Ahn SJ, Costa J, Emanuel JR. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res 1996, 24:2623-2625. 10.1093/nar/24.13.2623, 145983, 8692708.
37. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177.
38. Durigova M, Roughley PJ, Mort JS. Mechanisms of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M. Osteoarthritis Cart 2008, 16:98-104.
39. Alini M, Eisenstein SM, Ito K, Little C, Kettler AA, Masuda K, Melrose J, Ralphs J, Stokes I, Wilke HJ. Are animal models useful for studying human disc disorders/degeneration?. Eur Spine J 2008, 17:2-19. 10.1007/s00586-007-0414-y, 2365516, 17632738.
40. An HS, Masuda K. Relevance of in vitro and in vivo models for intervertebral disc degeneration. J Bone Joint Surg Am 2006, 88(Suppl 2):88-94.
41. Singh K, Masuda K, An HS. Animal models for human disc degeneration. Spine J 2005, 5:267S-279S. 10.1016/j.spinee.2005.02.016, 16291123.
42. Thompson JP, Pearce RH, Schechter MT, Adams ME, Tsang IK, Bishop PB. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 1990, 15:411-415. 10.1097/00007632-199005000-00012, 2363069.